A. J. Cochran, Tumour-induced immune modulation of sentinel lymph nodes, Nat. Rev. Immunol, vol.6, pp.659-670, 2006.

D. H. Munn and A. L. Mellor, The tumor-draining lymph node as an immuneprivileged site, Immunol. Rev, vol.213, pp.146-158, 2006.

Q. Tang, Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction, Immunity, vol.28, pp.687-697, 2008.

V. Galimberti and B. F. Cole, Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer -authors' reply, Lancet Oncol, vol.14, pp.251-252, 2013.

A. E. Giuliano, Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial, JAMA, vol.318, p.918, 2017.

M. A. Swartz and A. W. Lund, Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity, Nat. Rev. Cancer, vol.12, pp.210-219, 2012.

D. Jones, E. R. Pereira, and T. P. Padera, Growth and immune evasion of lymph node metastasis, Front. Oncol, vol.8, p.36, 2018.

Z. Faghih, Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes, Immunol. Lett, vol.158, pp.57-65, 2014.

J. H. Peters, Human secondary lymphoid organs typically contain polyclonally-activated proliferating regulatory T cells, Blood, vol.122, pp.2213-2223, 2013.

N. J. Poindexter, A. Sahin, K. K. Hunt, and E. A. Grimm, Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer, Breast Cancer Res, vol.6, p.408, 2004.

N. S. Zuckerman, Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients, Int. J. Cancer, vol.132, pp.2537-2547, 2013.

G. Plitas, Regulatory T cells exhibit distinct features in human breast cancer, Immunity, vol.45, pp.1122-1134, 2016.

B. Chaudhary and E. Elkord, Regulatory T cells in the tumor microenvironment and cancer progression: role and therapeutic targeting, Vaccines (Basel), vol.4, p.28, 2016.

G. J. Bates, Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at rsk of late relapse, JCO, vol.24, pp.5373-5380, 2006.

A. Merlo, FOXP3 expression and overall survival in breast cancer, JCO, vol.27, pp.1746-1752, 2009.

T. Duhen, R. Duhen, A. Lanzavecchia, F. Sallusto, and D. J. Campbell, Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells, Blood, vol.119, pp.4430-4440, 2012.

M. A. Kunicki, L. C. Amaya-hernandez, K. L. Davis, R. Bacchetta, and M. Roncarolo, Identity and diversity of human peripheral Th and T regulatory cells defined by single-cell mass, Cytom. J. I, vol.200, pp.336-346, 2018.

K. M. Van-pul, Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node, J. Immunother. Cancer, vol.7, p.133, 2019.

H. E. Kohrt, Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer, PLoS Med, vol.2, p.284, 2005.

R. Nakamura, Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer, Eur. J. Cancer, vol.45, pp.2123-2131, 2009.

M. Dougan, G. Dranoff, and S. K. Dougan, Cancer immunotherapy: beyond checkpoint blockade, Annu. Rev. Cancer Biol, vol.3, pp.55-75, 2019.

K. E. Yost, Clonal replacement of tumor-specific T cells following PD-1 blockade, Nat. Med, vol.25, pp.1251-1259, 2019.

S. Adams, Current landscape of immunotherapy in breast cancer: a review, JAMA Oncol, vol.5, p.1205, 2019.

R. H. Vonderheide, Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells, Clin. Cancer Res, vol.16, pp.3485-3494, 2010.

L. Wang, Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer, Nat. Immunol, vol.20, pp.1220-1230, 2019.

D. S. Chen and I. Mellman, Oncology meets immunology: the cancer-immunity cycle, Immunity, vol.39, pp.1-10, 2013.

B. Ruffell, Leukocyte composition of human breast cancer, Proc. Natl Acad. Sci, vol.109, pp.2796-2801, 2012.

M. Miyara, Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor, Immunity, vol.30, pp.899-911, 2009.

H. Nishikawa and S. Sakaguchi, Regulatory T cells in cancer immunotherapy, Curr. Opin. Immunol, vol.27, pp.1-7, 2014.

N. T. Joncker, Antigen-independent accumulation of activated effector/ memory T lymphocytes into human and murine tumors, Int. J. Cancer, vol.118, pp.1205-1214, 2006.

M. Dominguez-villar, C. M. Baecher-allan, and D. A. Hafler, Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease, Nat. Med, vol.17, pp.673-675, 2011.

A. E. Overacre-delgoffe, Interferon-? drives T reg fragility to promote anti-tumor immunity, Cell, vol.169, p.11, 2017.

M. Feuerer, J. A. Hill, D. Mathis, and C. Benoist, Foxp3+ regulatory T cells: differentiation, specification, subphenotypes, Nat. Immunol, vol.10, pp.689-695, 2009.

Y. D. Mahnke, T. M. Brodie, F. Sallusto, M. Roederer, and E. Lugli, The who's who of T-cell differentiation: human memory T-cell subsets: HIGHLIGHTS, Eur. J. Immunol, vol.43, pp.2797-2809, 2013.

T. Wang, The different T-cell receptor repertoires in breast cancer tumors, draining lymph nodes, and adjacent tissues, Cancer Immunol. Res, vol.5, pp.148-156, 2017.

H. Lee, J. L. Bautista, and C. Hsieh, Thymic and peripheral differentiation of regulatory T cells, Adv. Immunol, vol.112, pp.25-71, 2011.

W. Lee and G. R. Lee, Transcriptional regulation and development of regulatory T cells, Exp. Mol. Med, vol.50, p.456, 2018.

R. Alonso, Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node, Nat. Commun, vol.9, p.2113, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01976612

S. L. Buchan, Antibodies to costimulatory receptor 4-1bb enhance antitumor immunity via T regulatory cell depletion and promotion of CD8 T cell effector function, Immunity, vol.49, 2018.

T. Zhang, Aberrant frequency of TNFR2 + Treg and related cytokines in patients with CIN and cervical cancer, Oncotarget, vol.9, pp.5073-5083, 2018.

E. C. Halvorsen, IL-33 increases ST2 + Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner, OncoImmunology, vol.8, p.1527497, 2019.

E. Pastille, The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer, Mucosal Immunol, vol.12, pp.990-1003, 2019.

Y. Liu, FOXP3 and CEACAM6 expression and T cell infiltration in the occurrence and development of colon cancer, Oncol. Lett, vol.11, pp.3693-3701, 2016.

P. Gu, Trogocytosis of CD80 and CD86 by induced regulatory T cells, Cell Mol. Immunol, vol.9, pp.136-146, 2012.

V. Ovcinnikovs, CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells, Sci. Immunol, vol.4, p.902, 2019.

Y. Zhao, PD-L1:CD80 cis-heterodimer triggers the co-stimulatory receptor CD28 while repressing the inhibitory PD-1 and CTLA-4 pathways, Immunity, vol.51, pp.1059-1073, 2019.

A. M. Wolf, Increase of regulatory T cells in the peripheral blood of cancer patients, Clin. Cancer Res, vol.9, pp.606-612, 2003.

U. K. Liyanage, Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma, J. Immunol, vol.169, pp.2756-2761, 2002.

S. Sun, PD-1+ immune cell infiltration inversely correlates with survival of operable breast cancer patients, Cancer Immunol. Immunother, vol.63, pp.395-406, 2014.

R. Gupta, The numbers of FoxP3+ lymphocytes in sentinel lymph nodes of breast cancer patients correlate with primary tumor size but not nodal status, Cancer Investig, vol.29, pp.419-425, 2011.

X. Zhou, Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo, Nat. Immunol, vol.10, pp.1000-1007, 2009.

A. E. Overacre-delgoffe and D. A. Vignali, Treg fragility: a prerequisite for effective antitumor immunity?, Cancer Immunol. Res, vol.6, pp.882-887, 2018.

A. J. Furness, F. A. Vargas, K. S. Peggs, and S. A. Quezada, Impact of tumour microenvironment and Fc receptors on the activity of immunomodulatory antibodies, Trends Immunol, vol.35, pp.290-298, 2014.

J. M. Fritz and M. J. Lenardo, Development of immune checkpoint therapy for cancer, J. Exp. Med, vol.216, pp.1244-1254, 2019.

S. L. Buchan, A. Rogel, and A. Al-shamkhani, The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy, Blood, vol.131, pp.39-48, 2018.

N. Redjimi, CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity, Cancer Res, vol.72, pp.4351-4360, 2012.

S. A. Rosenberg and N. P. Restifo, Adoptive cell transfer as personalized immunotherapy for human cancer, Science, vol.348, pp.62-68, 2015.

Z. Hu, P. A. Ott, and C. J. Wu, Towards personalized, tumour-specific, therapeutic vaccines for cancer, Nat. Rev. Immunol, vol.18, pp.168-182, 2018.

C. Gu-trantien, CD4 + follicular helper T cell infiltration predicts breast cancer survival, J. Clin. Invest, vol.123, pp.2873-2892, 2013.

J. F. Beausang, T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire, Proc. Natl Acad. Sci. USA, vol.114, pp.10409-10417, 2017.

D. Zemmour, Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR, Nat. Immunol, vol.19, pp.291-301, 2018.

T. Maj, Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor, Nat. Immunol, vol.18, pp.1332-1341, 2017.

D. E. Speiser, P. Ho, and G. Verdeil, Regulatory circuits of T cell function in cancer, Nat. Rev. Immunol, vol.16, pp.599-611, 2016.

Z. Tatari-calderone, R. T. Semnani, T. B. Nutman, J. Schlom, and H. Sabzevari, Acquisition of CD80 by human T cells at early stages of activation: functional involvement of CD80 acquisition in T cell to T cell interaction, J. Immunol, vol.169, pp.6162-6169, 2002.

R. Bhairavabhotla, Transcriptome profiling of human FoxP3+ regulatory T cells, Hum. Immunol, vol.77, pp.201-213, 2016.

T. N. Schumacher and R. D. Schreiber, Neoantigens in cancer immunotherapy. Science, vol.348, pp.69-74, 2015.

N. Zacharakis, Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer, Nat. Med, vol.24, pp.724-730, 2018.

M. Nowicka, CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets, vol.6, p.748, 2017.

A. Han, J. Glanville, L. Hansmann, and M. M. Davis, Linking T-cell receptor sequence to functional phenotype at the single-cell level, Nat. Biotechnol, vol.32, pp.684-692, 2014.

D. A. Bolotin, MiXCR: software for comprehensive adaptive immunity profiling, Nat. Methods, vol.12, pp.380-381, 2015.